Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Current Assets (2021 - 2025)

Biote (BTMD) has 5 years of Current Assets data on record, last reported at $57.1 million in Q3 2025.

  • For Q3 2025, Current Assets fell 18.38% year-over-year to $57.1 million; the TTM value through Sep 2025 reached $57.1 million, down 18.38%, while the annual FY2024 figure was $68.1 million, 44.31% down from the prior year.
  • Current Assets reached $57.1 million in Q3 2025 per BTMD's latest filing, up from $49.5 million in the prior quarter.
  • Across five years, Current Assets topped out at $122.3 million in Q4 2023 and bottomed at $365674.0 in Q1 2022.
  • Average Current Assets over 5 years is $68.8 million, with a median of $68.7 million recorded in 2025.
  • Peak YoY movement for Current Assets: tumbled 75.62% in 2022, then skyrocketed 29285.74% in 2023.
  • A 5-year view of Current Assets shows it stood at $47.1 million in 2021, then skyrocketed by 114.88% to $101.2 million in 2022, then grew by 20.92% to $122.3 million in 2023, then tumbled by 44.31% to $68.1 million in 2024, then decreased by 16.15% to $57.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $57.1 million in Q3 2025, $49.5 million in Q2 2025, and $68.7 million in Q1 2025.